Terms: = Leukemia AND HNRNPA2B1, ENSG00000122566, SNRPB1, RNPA2, HNRPB1, HNRPA2, HNRNPB1, HNRNPA2, 3181 AND Treatment
4 results:
1. N6-methyladenosine in hematological malignancies: a concise review.
Wang WJ; Xu TT; Bao J
Curr Opin Hematol; 2023 Jan; 30(1):4-13. PubMed ID: 36165537
[TBL] [Abstract] [Full Text] [Related]
2. Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN).
Kong G; Grozinsky-Glasberg S; Hofman MS; Akhurst T; Meirovitz A; Maimon O; Krausz Y; Godefroy J; Michael M; Gross DJ; Hicks RJ
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):718-727. PubMed ID: 30343432
[TBL] [Abstract] [Full Text] [Related]
3. p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells.
Salesse S; Dylla SJ; Verfaillie CM
Leukemia; 2004 Apr; 18(4):727-33. PubMed ID: 14961028
[TBL] [Abstract] [Full Text] [Related]
4. Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and leukemia Group B.
Akerley W; Herndon JE; Egorin MJ; Lyss AP; Kindler HL; Savarese DM; Sherman CA; Rosen DM; Hollis D; Ratain MJ; Green MR
Cancer; 2003 May; 97(10):2480-6. PubMed ID: 12733147
[TBL] [Abstract] [Full Text] [Related]
